Latest Breaking News On - Siri lillegraven - Page 1 : vimarsana.com

Three-quarters of patients in RA remission flare within 3 years of TNF inhibitor taper

Three-quarters of patients in RA remission flare within 3 years of TNF inhibitor taper
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesShenaz baghaSiri lillegravenDiakonhjemmet hospitalDisease activity score

Three-quarters of patients in RA remission flare within 3 years of TNF inhibitor taper

Siri lillegravenShenaz baghaDiakonhjemmet hospitalDisease activity score

Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases

New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).

United statesSan diegoSiri lillegravenEuropean alliance for associationsAmerican college of rheumatologyResearch council of norwaySouth eastern norway regional health authorityAmerican collegeArthritis flareEuropean allianceDiakonhjemmet hospitalResearch councilSouth eastern norway regional healthRheumatoid arthritisTnf inhibitorTumor necrosis factor

Rheumatoid Arthritis Patients in Remission Withdrawing from TNF Inhibition Show Flare Increases

New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued TNFi.

United statesSan diegoSiri lillegravenSouth eastern norway regional health authorityAmerican college of rheumatologyEuropean alliance for associationsResearch council of norwayAmerican collegeEuropean allianceDiakonhjemmet hospitalResearch councilSouth eastern norway regional healthWithdrawal comparedAmong rheumatoid arthritis patientsSustained remissionMulticenter randomized trial

RA patients in remission should continue TNF inhibitors to avoid flares, study finds

New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi) had significantly more flares and lower Boolean 2.0 remission rates compared with those who continued treatment.

Siri lillegravenAmerican college of rheumatologyEuropean alliance for associationsAmerican collegeEuropean allianceDiakonhjemmet hospitalRheumatoid arthritis